Identify the suppliers that can serve your target markets

Name the molecules and the markets you sell into. PharmaDB checks every supplier against the public registers and returns a supplier map with the evidence behind each one.

No payment details needed. You can also browse 305 molecule pages and 1,710 supplier profiles without an account →

What every map contains

Each map assembles the work a sourcing team would otherwise carry out by hand across five separate databases.

Suppliers placed in tiers
Every supplier sits in one of three tiers: Strong candidate, Promising or Insufficient evidence. The map states the evidence behind each placement.
Standing in your markets
Each supplier is marked as an incumbent, present with other products, or not registered in your market.
Price corridor
The map reports the range at which the API currently exports, and how many exporters set it.
Market size and supply concentration
The map sizes the market and shows how concentrated supply is among the manufacturers serving it.
IP and freedom to operate
The map sets out the patents and exclusivities standing between you and the market, before you commit to a filing.
Access channels
Traders, agents and distributors are sourcing routes, not manufacturing sites, so they carry no tier. Each entry names the organisation, its country, the channel type, the manufacturers represented and the evidence.
A prefilled Request for Information sheet
Anything public records cannot answer becomes a question on a sheet that is ready to send.

Every claim is labelled with its basis

Each statement on a map carries a label showing how it was established. Where the public record is silent, the map says so rather than filling the gap.

Anchored
The claim is tied to a public register, with the identifier and the date it was read.
Labeled estimate
The figure comes from a named dataset, and the method is shown.
Self reported
The claim comes from a company disclosure and is cited as such.
RFI item
The item is not in public records, so it goes onto the RFI sheet you send.
Not established
The register was checked and the date recorded. The map reports the gap rather than inferring an answer.

Every map is versioned, so re-running one shows what has changed. The whole map exports as a PDF.

Start for free Setting up takes about a minute. The finished map appears in your workspace.

The directory is free to browse

You can read 305 molecule pages and 1,710 supplier profiles without an account. Every figure carries its regulator source and the date it was retrieved.

All 305 molecules →
Rivaroxaban
81 manufacturers
Sitagliptin
67 manufacturers
Esomeprazole
61 manufacturers
Pantoprazole
61 manufacturers
Semaglutide
61 manufacturers
Paracetamol
60 manufacturers
Rosuvastatin
60 manufacturers
Pregabalin
59 manufacturers

Supplier profiles

All 1,710 suppliers →
Apitoria Pharma
303 US DMFs · 173 CEPs
Hetero
380 US DMFs · 67 CEPs
Cipla
161 US DMFs · 272 CEPs
Dr. Reddy's Laboratories
270 US DMFs · 90 CEPs
605,422
companies indexed
1,623,651
regulatory filings
203
countries covered

These counts come from the warehouse snapshot of 9 July 2026 and are recomputed on every build. A manufacturer holds an active US DMF or a valid CEP, not merely an offer to sell. Read how we count these figures →